{"id":162369,"date":"2024-07-24T10:00:56","date_gmt":"2024-07-24T07:00:56","guid":{"rendered":"https:\/\/www.tehnopol.ee\/?p=162369"},"modified":"2024-11-25T13:48:18","modified_gmt":"2024-11-25T11:48:18","slug":"muun-health-a-new-member-of-the-healthtech-community-aims-to-solve-a-global-problem","status":"publish","type":"post","link":"https:\/\/www.tehnopol.ee\/en\/muun-health-a-new-member-of-the-healthtech-community-aims-to-solve-a-global-problem\/","title":{"rendered":"Muun Health is a new member of the HealthTech Community that is working to solve a global problem"},"content":{"rendered":"<p><strong>Tehnopol has welcomed an innovative new company called Muun Health to its health technology community. Muun Health is revolutionising hormonal health. Tehnopol\u2019s mission is to support entrepreneurship and innovation in world-changing technology by providing a comprehensive growth environment where companies can thrive and develop through innovation and expert business consulting.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-addressing-a-major-global-issue\"><strong>Addressing a major global issue<\/strong><\/h2><p style='margin-right: 0cm; margin-left: 0cm; font-size: 12pt; font-family: \"Times New Roman\", serif; font-weight: 400; white-space-collapse: collapse;'><span lang=\"EN-GB\" style=\"font-size: 14pt;\"><\/span><\/p>\n\n\n\n<p><a href=\"https:\/\/www.who.int\/news\/item\/04-04-2023-1-in-6-people-globally-affected-by-infertility\" target=\"_blank\" rel=\"noreferrer noopener\">The World Health Organization estimates<\/a> that one in six people worldwide faces infertility issues. The scale of this problem highlights how urgent the need is for affordable and high-quality solutions. Conception can take several months even if there are no infertility problems, leading people to seek anything that could simplify the process, from ovulation tests to blood tests and more. But what if hormonal changes could be continuously monitored? This is exactly the problem Muun Health is aiming to solve with its innovative approach.<\/p>\n\n\n\n<p>Muun Health was founded in 2023. The company\u2019s founder, <strong>Kerli Luks<\/strong>, has a medical background with over a decade of experience working in various hospitals and clinics both in Estonia and abroad. \u201cDuring clinical work, the need for continuous monitoring of female hormones became increasingly apparent, as current methods of analysis do not adequately reflect hormonal balance\u201d, she explained. Of particular importance is that the fluctuations of female sex hormones require constant monitoring throughout the menstrual cycle, which cannot be done using current methods.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-synergy-between-innovation-and-scientific-research\"><strong>Synergy between innovation and scientific research<\/strong><\/h2>\n\n\n\n<p>There are hundreds of methods and devices on the market for determining ovulation, but Muun Health is working to create a biosensor that is the simplest, fastest and most accurate of them. Muun Health\u2019s device continuously measures female sex hormone levels, providing more information than other ovulation monitoring devices. Innovation and scientific research are integral parts of the company. \u201cOnly in this way can we create new personalised solutions that are also clinically significant\u201d, said Luks.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"426\" src=\"https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-1024x426.jpeg\" alt=\"\" class=\"wp-image-162370\" srcset=\"https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-1024x426.jpeg 1024w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-300x125.jpeg 300w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-768x319.jpeg 768w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-1536x638.jpeg 1536w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-400x166.jpeg 400w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-200x83.jpeg 200w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-1440x599.jpeg 1440w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut-600x249.jpeg 600w, https:\/\/www.tehnopol.ee\/wp-content\/uploads\/2024\/07\/Lab-stock-image_cut.jpeg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\"><figcaption class=\"wp-element-caption\"><em>Image used for illustrative purposes only.<\/em><\/figcaption><\/figure>\n\n\n\n<p>The method that Muun Health uses to determine female sex hormones was created over ten years ago, but it has been extensively modified for use in their biosensor. The innovative process leverages new knowledge, earlier experience, and the scientific literature to create a completely new device that has great potential for the long term. In the future they plan to measure the levels of multiple hormones simultaneously, leading to even greater breakthroughs in health technology.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-promising-early-results\"><strong>Promising early results<\/strong><\/h2><p style='margin-right: 0cm; margin-left: 0cm; font-size: 12pt; font-family: \"Times New Roman\", serif; font-weight: 400; white-space-collapse: collapse;'><span lang=\"EN-GB\" style=\"font-size: 14pt;\"><\/span><\/p>\n\n\n\n<p>The response to Muun Health\u2019s product has been very positive. There is a lot of interest in the device, especially among the target group of women aged 28-40. Luks stated that the next steps include further product development and creation of a prototype, followed by clinical trials and production work. The goal is to launch the device in the US market first, and then expand to the UK and European markets.<\/p>\n\n\n\n<p>Although Muun Health only began laboratory testing in January this year, they have achieved a lot in a short time. A significant accomplishment is that they have proved that their method can determine the concentration of female sex hormones in interstitial fluid, which is about one hundredth of the level in serum.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-expectations-for-joining-tehnopol-s-healthtech-community\"><strong>Expectations for joining Tehnopol\u2019s HealthTech Community<\/strong><span style=\"font-size: medium; font-weight: 400; white-space-collapse: collapse;\"><\/span><\/h2>\n\n\n\n<p>Muun Health founder Kerli Luks sees Tehnopol\u2019s health technology community as a crucial support system for bringing the product to market. As the largest health-related ecosystem in the Baltics, Tehnopol offers the chance to learn from the experience of network members and to find partners to work with. Members can also participate in information events and receive mentor support in developing and implementing their strategy. The goal for Muun Health is to move into foreign markets, where they see that Tehnopol can provide significant support.<\/p>\n\n\n\n<p>We are pleased to welcome Muun Health to Tehnopol\u2019s health technology community and we look forward to seeing how their innovative solution simplifies the lives of families around the world!<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\">\n\n\n\n<p><em>Do you want to join Estonia\u2019s most innovative health technology community? A strong community awaits, along with extensive collaboration opportunities and support for exploring new export markets.<br><a href=\"https:\/\/www.tehnopol.ee\/en\/business-services\/health-tech-community\/\">Read more here and get in touch with us<\/a>!<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tehnopol has welcomed an innovative new company called Muun Health to its health technology community. Muun Health is revolutionising hormonal health. Tehnopol\u2019s mission is to support entrepreneurship and innovation in world-changing technology by providing a comprehensive growth environment where companies can thrive and develop through innovation and expert business consulting. Addressing a major global issue [&hellip;]<\/p>\n","protected":false},"author":31,"featured_media":161037,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_s2mail":"yes","footnotes":""},"categories":[194],"tags":[],"class_list":["post-162369","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-technologies"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/posts\/162369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/comments?post=162369"}],"version-history":[{"count":2,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/posts\/162369\/revisions"}],"predecessor-version":[{"id":162656,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/posts\/162369\/revisions\/162656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/media\/161037"}],"wp:attachment":[{"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/media?parent=162369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/categories?post=162369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tehnopol.ee\/en\/wp-json\/wp\/v2\/tags?post=162369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}